VHA breast cancer molecular testing BPA
Ended Awarded Last action
- Contract number
- 36C10X24F0099
- Awardee
-
Exact Sciences Corporation UEI NGBXEJX5GLE9
- Awarding agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Obligated
- $438,653
Award facts
- Contract value 100% obligated
- $438,652.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53719, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$58,717 | |
| Original award | $497,370 |
About this award
The Department of Veterans Affairs, through its Strategic Acquisition Center Frederick, awarded a modification to Exact Sciences Corporation under the VHA Breast Cancer Molecular Testing Blanket Purchase Agreement (BPA) on September 1, 2024. This modification decreases contract line-item number 0001 by removing excess quantities and de-obligating associated funds, effectively closing out the task order. The contract operates under a firm fixed-price structure with a ceiling value of $438,652.92 and an ultimate completion date of August 31, 2025. The work is performed at Exact Sciences Laboratories, LLC's facility in Madison, Wisconsin, with no small business set-aside designation applied.
Exact Sciences Corporation, a leading medical technology company specializing in advanced diagnostic testing for cancer screening and detection, provided molecular testing services for breast cancer under this BPA, which falls under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The company's expertise in gene expression profiling and genomic testing, particularly through its Oncotype DX series of assays, positions it as a key provider of specialized diagnostic services to federal healthcare agencies. This contract modification represents the closure of a task order within Exact Sciences' broader portfolio of federal cancer testing contracts across the VA and Defense Health Agency, demonstrating the company's sustained role in supporting personalized medicine initiatives within the federal healthcare system.
Quick answers
Who was awarded contract 36C10X24F0099?
36C10X24F0099 was awarded to Exact Sciences Corporation by VA Strategic Acquisition Center Frederick (Headquarters) on September 1, 2024.
How much is contract 36C10X24F0099 worth?
The government has obligated $438,653 on 36C10X24F0099.
Is contract 36C10X24F0099 an order under another contract?
Yes. 36C10X24F0099 is a BPA call under V797D70053-36C10X24A0011, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C10X24F0099 competed?
The extent of competition for 36C10X24F0099 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award